Printer Friendly
The Free Library
14,599,653 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ELAST Technologies Commences Production of Chiropractic Bio-Potential Instrument and Expects To Deliver Initial Units by Spring.


Business Editors

LAS VEGAS--(BUSINESS WIRE)--Jan. 11, 2001

ELAST Technologies, Inc., (OTC-BB: ELTI ELTI English Language Training Institute (UNC Charlotte)
ELTI Excellence in Learning and Teaching Initiative
ELTI Embedding Learning Technology Institutionally (UK e-learning)
ELTI Elapsed Time Indicator
) www.elast.com announced that it has begun the production of its chiropractic chiropractic (kīrəprăk`tĭk) [Gr.,=doing by hand], medical practice based on the theory that all disease results from a disruption of the functions of the nerves.  outcome measurement instrument -- the Bio-Potential Instrument -- and that it expects to deliver initial units by the 2nd quarter of this year.

ELAST's Bio-Potential Instrument can provide doctors of chiropractic with the means to objectively measure vertebral subluxations, (small misalignments of the vertebrae Vertebrae
Bones in the cervical, thoracic, and lumbar regions of the body that make up the vertebral column. Vertebrae have a central foramen (hole), and their superposition makes up the vertebral canal that encloses the spinal cord.
 which interfere with the normal nerve flow) as well as the normalizing effect of chiropractic spinal adjustments spinal adjustment Chiropractic The main type of treatment provided by chiropractors; the most common SA used in chiropractic is a high-velocity, low-force recoil thrust and rotational thrust. See Chiropractic, Recoil thrust, Rotational thrust, Spinal misalignment.  through its ability to measure the body's electrical flow. The Bio-Potential Instrument can provide these measurements immediately and in real time thereby assisting chiropractors in establishing care parameters and encouraging patient understanding and compliance by demonstrating the efficacy of subluxation subluxation /sub·lux·a·tion/ (sub?luk-sa´shun)
1. incomplete or partial dislocation.

2. in chiropractic, any mechanical impediment to nerve function; originally, a vertebral displacement believed to impair nerve
 corrective care.

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 Thomas F. Krucker, ELAST President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , "doctors of chiropractic have long sought objective means to measure changes that occur after the correction of vertebral subluxation. ELAST's Bio-Potential Instrument will enable chiropractors to analyze and quantify subluxation correction in a new and very significant way." Mr. Krucker believes the chiropractic market can provide strong revenues for the Company.

In an effort to meet that projection ELAST established a chiropractic division in August 2000 dedicated to marketing the Bio-Potential Instrument to the chiropractic community. ELAST contracted with the Terry A. Rondberg, DC, to head the new division. Dr. Rondberg is president of the World Chiropractic Alliance and publisher of The Chiropractic Journal. He is the author of numerous articles on chiropractic for both the profession and the public, as well as several best-selling books. He publishes the Journal of Vertebral Subluxation Research, a scientific peer-reviewed journal peer-reviewed journal Refereed journal Academia A professional journal that only publishes articles subjected to a rigorous peer validity review process. Cf Throwaway journal. , and the weekly online newsletter Health Watch. ELAST plans delivery of its first production run of Bio-Potential Instruments to the chiropractic profession immediately upon their completion in the Spring of 2001.

This news release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product development and consumer demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, impact of competition and pricing, capacity and supply constraints or difficulties, government regulations and other risks. All such forward-looking statements, whether written or oral, and whether made by or on behalf of ELAST Technologies, Inc., are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, ELAST Technologies, Inc., disclaims any obligation to update any forward-looking statement to reflect events or circumstances after the date hereof.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 11, 2001
Words:453
Previous Article:DispenseSource Inc. Secures $10 Million Equity Investment.
Next Article:Starbase Corp. Selected to Manage PDA Development Effort For AppForge, Inc.; StarTeam Selected as Development Standard To Manage All Code and Content.



Related Articles
Curing time software in theory and practice.
ELAST Technologies Appoints Dr. Robert H.I. Blanks to Spearhead Advanced R&D And Manufacturing Efforts.
ELAST Technologies Unveils Bio-Potential Instrument.
ELAST Technologies Unveils Bio-Potential Instrument.
ELAST Technologies Secures Beta Site Installations of Bio-Potential Instrument.
Injection molding. (Literature: equipment).(Brief Article)
Chem-Bio detector market reaches $400M.(Statistical Data Included)(Industry Overview)
City's strategy bears fruit.(COMMUNITIES OF THE NORTH)
BIO-BRIDGE SIGNS DISTRIBUTION PACT WITH XINHUA SURGICAL.
Vertical machine features new clamp design.(Equipment)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles